Search Page

1

Cite

Share

(Mis)understanding the treatment team and the measurement of outcomes in breast reconstruction.

Popowich B, Kostaras X, Webb C, Temple-Oberle C. Popowich B, et al. Among authors: kostaras x. Eur J Surg Oncol. 2021 May;47(5):1228-1229. doi: 10.1016/j.ejso.2020.12.012. Epub 2020 Dec 19. Eur J Surg Oncol. 2021. PMID: 33468372 No abstract available.

Cite

Share

2

Cite

Share

Breast reconstruction after therapeutic or prophylactic mastectomy for breast cancer: A comparison of guideline recommendations.

Popowich B, Kostaras X, Temple-Oberle C. Popowich B, et al. Among authors: kostaras x. Eur J Surg Oncol. 2020 Jun;46(6):1046-1051. doi: 10.1016/j.ejso.2020.01.024. Epub 2020 Jan 18. Eur J Surg Oncol. 2020. PMID: 32057564 Review.

Cite

Share

3

Cite

Share

Management of recurrent medulloblastoma in adult patients: a systematic review and recommendations.

Kostaras X, Easaw JC. Kostaras X, et al. J Neurooncol. 2013 Oct;115(1):1-8. doi: 10.1007/s11060-013-1206-3. Epub 2013 Jul 23. J Neurooncol. 2013. PMID: 23877361 Review.

Cite

Share

4

Cite

Share

Benefits and risks to mother and infant of drug treatment for postnatal depression.

Misri S, Kostaras X. Misri S, et al. Among authors: kostaras x. Drug Saf. 2002;25(13):903-11. doi: 10.2165/00002018-200225130-00002. Drug Saf. 2002. PMID: 12381212 Review.

Cite

Share

5

Cite

Share

Real-World Outcomes of Adjuvant Chemotherapy for Node-Negative and Node-Positive HER2-Positive Breast Cancer.

Veitch Z, Khan OF, Tilley D, Ribnikar D, Kostaras X, King K, Tang P, Lupichuk S. Veitch Z, et al. Among authors: kostaras x. J Natl Compr Canc Netw. 2019 Jan;17(1):47-56. doi: 10.6004/jnccn.2018.7066. J Natl Compr Canc Netw. 2019. PMID: 30659129

Cite

Share

6

Cite

Share

Impact of Cumulative Chemotherapy Dose on Survival With Adjuvant FEC-D Chemotherapy for Breast Cancer.

Veitch Z, Khan OF, Tilley D, Tang PA, Ribnikar D, Stewart DA, Kostaras X, King K, Lupichuk S. Veitch Z, et al. Among authors: kostaras x. J Natl Compr Canc Netw. 2019 Aug 1;17(8):957-967. doi: 10.6004/jnccn.2019.7286. J Natl Compr Canc Netw. 2019. PMID: 31390594

Cite

Share

7

Cite

Share

An audit of referral and treatment patterns of high-risk prostate cancer patients in Alberta.

Alghamdi M, Taggar A, Tilley D, Kerba M, Kostaras X, Gotto G, Sia M. Alghamdi M, et al. Among authors: kostaras x. Can Urol Assoc J. 2016 Nov-Dec;10(11-12):410-415. doi: 10.5489/cuaj.3910. Can Urol Assoc J. 2016. PMID: 28096916 Free PMC article.

Cite

Share

8

Cite

Share

Information needs and sources of information for patients during cancer follow-up.

Shea-Budgell MA, Kostaras X, Myhill KP, Hagen NA. Shea-Budgell MA, et al. Among authors: kostaras x. Curr Oncol. 2014 Aug;21(4):165-73. doi: 10.3747/co.21.1932. Curr Oncol. 2014. PMID: 25089098 Free PMC article.

Cite

Share

9

Cite

Share

A population-based assessment of melanoma: Does treatment in a regional cancer center make a difference?

Rivard J, Kostaras X, Shea-Budgell M, Chin-Lenn L, Quan ML, McKinnon JG. Rivard J, et al. Among authors: kostaras x. J Surg Oncol. 2015 Aug;112(2):173-8. doi: 10.1002/jso.23981. J Surg Oncol. 2015. PMID: 26445222

Cite

Share

10

Cite

Share

Update to the Canadian clinical practice guideline for best-practice management of breast cancer-related lymphedema: study protocol.

McNeely ML, Harris SR, Dolgoy ND, Al Onazi MM, Parkinson JF, Radke L, Kostaras X, Dennett L, Ryan JA, Dalzell MA, Kennedy A, Capozzi L, Towers A, Campbell KL, Binkley J, King K, Keast D. McNeely ML, et al. Among authors: kostaras x. CMAJ Open. 2022 Apr 12;10(2):E338-E347. doi: 10.9778/cmajo.20210038. Print 2022 Apr-Jun. CMAJ Open. 2022. PMID: 35414596 Free PMC article.

Cite

Share